Serotonin is critically involved in neuropathic pain. However, its role is far from being understood owing to the number of cellular targets and receptor subtypes involved. In a rat model of neuropathic pain evoked by chronic constriction injury (CCI) of the sciatic nerve, we studied the role of 5-HT 2B receptor in dorsal root ganglia (DRG) and the sciatic nerve. We showed that 5-HT 2B receptor activation both prevents and reduces CCI-induced allodynia. Intrathecal administration of 5-HT 2B receptor agonist BW723C86 significantly attenuated established mechanical and cold allodynia; this effect was prevented by co-injection of RS127445, a selective 5-HT 2B receptor antagonist. A single application of BW723C86 on the sciatic nerve concomitantly to CCI dose-dependently prevented mechanical allodynia and significantly reduced cold allodynia 17 days after CCI. This behavioral effect was accompanied with a marked decrease in macrophage infiltration into the sciatic nerve and, in the DRG, with an attenuated abnormal expression of several markers associated with local neuroinflammation and neuropathic pain. CCI resulted in a marked upregulation of 5-HT 2B receptor expression in sciatic nerve and DRG. In the latter structure, it was biphasic, consisting of a transient early increase (23-fold), 2 days after the surgery and before the neuropathic pain emergence, followed by a steady (5-fold) increase, that remained constant until pain disappeared. In DRG and sciatic nerve, 5-HT 2B receptors were immunolocalized on sensory neurons and infiltrating macrophages. Our data reveal a relationship between serotonin, immunocytes, and neuropathic pain development, and demonstrate a critical role of 5-HT 2B receptors in blood-derived macrophages.
Serotonin is critically involved in neuropathic pain. However, its role is far from being understood owing to the number of cellular targets and receptor subtypes involved. In a rat model of neuropathic pain evoked by chronic constriction injury (CCI) of the sciatic nerve, we studied the role of 5-HT 2B receptor in dorsal root ganglia (DRG) and the sciatic nerve. We showed that 5-HT 2B receptor activation both prevents and reduces CCI-induced allodynia. Intrathecal administration of 5-HT 2B receptor agonist BW723C86 significantly attenuated established mechanical and cold allodynia; this effect was prevented by co-injection of RS127445, a selective 5-HT 2B receptor antagonist. A single application of BW723C86 on the sciatic nerve concomitantly to CCI dose-dependently prevented mechanical allodynia and significantly reduced cold allodynia 17 days after CCI. This behavioral effect was accompanied with a marked decrease in macrophage infiltration into the sciatic nerve and, in the DRG, with an attenuated abnormal expression of several markers associated with local neuroinflammation and neuropathic pain. CCI resulted in a marked upregulation of 5-HT 2B receptor expression in sciatic nerve and DRG. In the latter structure, it was biphasic, consisting of a transient early increase (23-fold), 2 days after the surgery and before the neuropathic pain emergence, followed by a steady (5-fold) increase, that remained constant until pain disappeared. In DRG and sciatic nerve, 5-HT 2B receptors were immunolocalized on sensory neurons and infiltrating macrophages. Our data reveal a relationship between serotonin, immunocytes, and neuropathic pain development, and demonstrate a critical role of 5-HT 2B receptors in blood-derived macrophages. Ó 2012 International Association for the Study of Pain. Published by Elsevier B.V. All rights reserved.
Introduction
Painful peripheral sensory neuropathies that may appear after peripheral nerve alterations involve complex changes to nociceptor function. The sensitization of peripheral nociceptors and of spinal and supraspinal relay cells leads to a persistent pain syndrome including abnormal pain sensations such as hyperalgesia (enhanced pain in response to a painful stimulus) and allodynia (pain sensation after an innocuous stimulus) [4, 28, 38, 60, 69] . Emerging evidence shows that the immune system plays a critical role in both the development and maintenance of pain [5, 15, 43, 57] . In the peripheral nervous system, circulating monocytes, granulocytes, and lymphocytes infiltrate the site of injured nerves, and various signaling molecules produced by these cells participate in complex alterations, leading to neuropathic pain emergence.
The principal treatments for neuropathic pain include antidepressants, mixed serotonin (5-HT), and noradrenaline reuptake inhibitors exerting their analgesic effect at both peripheral and central levels [3, 22] . Despite major alterations to 5-HT functions in neuropathic pain, specific 5-HT reuptake inhibitors are poorly effective for the relief of neuropathic pain. Indeed, pain modulation by 5-HT is multifaceted and may involve pro-or antinociceptive effects, depending on cellular targets and receptor subtypes involved. Peripheral 5-HT, released by mast cells following both inflammation and nerve injury, sensitizes nociceptors [61] . In the spinal cord, central 5-HT, mainly acting through bulbospinal descending projections, modulates nociceptive transmission in a complex way [30, 42, 53, 62] . However, the role of 5-HT in immune mechanisms associated with neuropathic pain has never been 
